Entecavir (Baraclude), an inhibitor of hepatitis B virus DNA polymerase, is the latest approved antiviral agent for chronic hepatitis B. Researchers examined the efficacy of entecavir in two ...

patients receiving once daily doses of ALG-000184 as monotherapy or in combination with entecavir (ETV) x ≤ 64 weeks Dosing continues in this ongoing Phase 1a/1b study, with subjects planning to dose ...

The trial is evaluating 248 patients with a primary endpoint of the reduction of the liver fibrosis score (Ishak Scoring System) by at least one grade after taking F351 in combination with entecavir.

Phase 3 clinical trial evaluating F351 for the treatment of CHB-associated liver fibrosis in the PRC remains on track with data anticipated by early 2025 U.S. IND submission to evaluate F351 for the ...

Lamivudine, entecavir* or telbivudine* Add or switch to tenofovir ‡ (add adefovir, if tenofovir not available) Adefovir* Replace adefovir with tenofovir and add lamivudine, entecavir or ...

Viral inactivated vaccines play a fundamental role in animal heath, both for individual protection and for the induction of antibodies that will be passively transmitted to the progeny. Depending on ...

Effect of other variables was estimated using subgroup analysis and meta-regression. Studies including patients stopping entecavir (ETV) and/or tenofovir disoproxil fumarate (TDF) were considered ...

Results From a healthcare system perspective, the treat-IT strategy with entecavir or tenofovir had an ICER of US$16 516/QALY, with an annual hepatocellular carcinoma (HCC) incidence of 0.73% in the ...

The company offers prescription products such as iohexol, arginine thiazolidine carboxylate, domperidone maleate, adefovir dipivoxil, entecavir, trimebutine maleate and omeprazole enteric granule, ...

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...

Researchers assessed associations between biomarkers of acetaminophen exposure in cord blood and school-age asthma, with and without other allergic conditions.